Biotech | March 07, 2022
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Serina has over 17 years of experience in the biopharmaceutical industry
PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains
AROC3-1001 is a phase 1/2, placebo controlled, dose-escalating study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARO-C3
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
The audit is a PAI for two of its product applications filed from this facility
Glenmark’s current portfolio consists of 173 products authorized for distribution in the U.S. marketplace and 46 ANDA’s pending approval with the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
